Dermacaine
Brand names,
Dermacaine
Analogs
Dermacaine
Brand Names Mixture
Dermacaine
Chemical_Formula
C21H27NO
Dermacaine
RX_link
No information avaliable
Dermacaine
fda sheet
Dermacaine
msds (material safety sheet)
Dermacaine
Synthesis Reference
No information avaliable
Dermacaine
Molecular Weight
309.445 g/mol
Dermacaine
Melting Point
No information avaliable
Dermacaine
H2O Solubility
No information avaliable
Dermacaine
State
Solid
Dermacaine
LogP
4.86
Dermacaine
Dosage Forms
Tablets for oral administration (25 mg, 50 mg)
Dermacaine
Indication
For use in the prevention and symptomatic treatment of peripheral (labyrinthine) vertigo and associated nausea and vomiting that occur in such conditions as Meniere's disease and surgery of the middle and inner ear. Also for the control of nausea and vomiting associated with postoperative states, malignant neoplasms, labyrinthine disturbances, antineoplastic agent therapy, radiation sickness, and infectious diseases.
Dermacaine
Pharmacology
No information avaliable
Dermacaine
Absorption
Well absorbed from gastrointestinal tract following oral administration.
Dermacaine
side effects and Toxicity
Symptoms of overdose include drowsiness (severe); shortness of breath or troubled breathing; unusual tiredness or weakness (severe).
Dermacaine
Patient Information
No information avaliable
Dermacaine
Organisms Affected
Humans and other mammals